US pharmaceutics giant Merck was severely affected by the NotPetya ransomware outbreak that took place at the end of June, and the company is still struggling to restore all systems and resume normal operations, according to an 8-K report filed with the US Securities and Exchange Commission (SEC). […]

from https://www.bleepingcomputer.com/news/security/us-pharma-giant-not-yet-producing-bulk-product-because-of-notpetya-outbreak/